Live Attenuated Flu Vaccine Not Effective for Children in 2015 - 16

Overall, influenza vaccine was 48 percent effective against any influenza illness for 2015 to 2016 season
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Nursing, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news

Related Links:

CONCLUSIONS: Active promotion and information regarding beneficial role of immunizations among IBD patients and other chronically ill individuals significantly improves the quality of care. It is important to explain misconceptions about vaccines by the most reliable sources. We propose implementing an uniformed "immunization chart" for every chronically ill individual. PMID: 30024696 [PubMed - in process]
Source: Acta Gastro-Enterologica Belgica - Category: Gastroenterology Tags: Acta Gastroenterol Belg Source Type: research
Publication date: Available online 19 July 2018Source: Academic PediatricsAuthor(s): Alison Saville, Peter Szilagyi, Laura Helmkamp, Christina Albertin, Dennis Gurfinkel, Sitaram Vangela, L. Miriam Dickinson, Xinkai Zhou, Heather Roth, Allison KempeAbstractObjectivesChildhood influenza vaccination rates remain sub-optimal. Provider perceptions on strategies to achieve universal vaccination are needed. We assessed perceptions and attitudes of primary care providers across two states regarding two strategies to potentially bolster rates: Centralized-Reminder/Recall (C-R/R), such as R/R from state immunization registries; and...
Source: Academic Pediatrics - Category: Pediatrics Source Type: research
Funding to support research activities that will advance NIAIDs mission to develop a universal influenza vaccine providing durable protection against multiple influenza strains, including efforts to: 1) improve understanding of transmission, natural history and pathogenesis of influenza virus infection; 2) characterize influenza immunity and correlates of immune protection; and 3) support rational design of universal influenza vaccines.
Source: PHPartners.org - Category: International Medicine & Public Health Source Type: news
AbstractEcological investigations of silkworms have revealed that Eri silkworms (Samia cynthia ricini) possess useful morphological and ecological characteristics for virus-like particle (VLP) production, namely non-seasonal breeding, longer lengths, and heavier weights thanBombyx mori silkworms. Furthermore, when vector DNA from Bombyx mori nuclear polyhedrosis virus (BmNPV), which is unable to replicate in Sf9 cells from Eri silkworms, was replaced with the Autographa californica nuclear polyhedrosis virus (AcNPV) vector, three improved AcNPV influenza virus recombinants capable of replication in Sf9 cells were obtained....
Source: Archives of Virology - Category: Virology Source Type: research
Funding Opportunity PA-18-859 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support research activities that will advance NIAIDs mission to develop a universal influenza vaccine providing durable protection against multiple influenza strains, including efforts to: 1) improve understanding of transmission, natural history and pathogenesis of influenza virus infection; 2) characterize influenza immunity and correlates of immune protection; and 3) support rational design of universal influenza vaccines. This FOA uses the R01 grant mechanism, while the companion FOA, P...
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding
Funding Opportunity PA-18-858 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support research activities that will advance NIAIDs mission to develop a universal influenza vaccine providing durable protection against multiple influenza strains, including efforts to: 1) improve understanding of transmission, natural history and pathogenesis of influenza virus infection; 2) characterize influenza immunity and correlates of immune protection; and 3) support rational design of universal influenza vaccines. This FOA uses the R21 grant mechanism, while the companion FOA, P...
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding
Conditions:   Avian Influenza;   Influenza Immunisation Interventions:   Biological: A/H7N9;   Drug: AS03;   Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013;   Other: Phosphate Buffered Saline (PBS) diluent Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Influenza;   Solid Carcinoma Intervention:   Biological: Influenza vaccination Sponsors:   Seoul National University Hospital;   Green Cross Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Avian Influenza;   Influenza Immunisation Interventions:   Biological: A/H7N9;   Drug: AS03;   Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013;   Other: Phosphate Buffered Saline (PBS) diluent Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Influenza;   Solid Carcinoma Intervention:   Biological: Influenza vaccination Sponsors:   Seoul National University Hospital;   Green Cross Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Children | Influenza | Influenza Vaccine | Internal Medicine | Nurses | Nursing | Pediatrics | Respiratory Medicine | Vaccines